Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 12 | 2023 | 192 | 4.720 |
Why?
|
| Neuromyelitis Optica | 1 | 2023 | 7 | 0.890 |
Why?
|
| Sjogren's Syndrome | 1 | 2023 | 5 | 0.890 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 47 | 0.830 |
Why?
|
| Pneumococcal Infections | 1 | 2021 | 7 | 0.780 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2021 | 9 | 0.780 |
Why?
|
| Quality of Life | 3 | 2023 | 655 | 0.770 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2018 | 15 | 0.630 |
Why?
|
| Rheumatologists | 1 | 2018 | 15 | 0.620 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 25 | 0.610 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 38 | 0.610 |
Why?
|
| Rheumatology | 2 | 2018 | 85 | 0.610 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 990 | 0.570 |
Why?
|
| Quality of Health Care | 2 | 2023 | 126 | 0.380 |
Why?
|
| Humans | 13 | 2023 | 28054 | 0.330 |
Why?
|
| Middle Aged | 7 | 2023 | 9186 | 0.290 |
Why?
|
| Adult | 9 | 2023 | 8021 | 0.290 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 449 | 0.260 |
Why?
|
| Female | 8 | 2023 | 15534 | 0.240 |
Why?
|
| Paraplegia | 1 | 2023 | 6 | 0.220 |
Why?
|
| Seizures | 1 | 2023 | 67 | 0.210 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 9 | 0.210 |
Why?
|
| Vasospasm, Intracranial | 1 | 2022 | 10 | 0.200 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2022 | 5 | 0.200 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2022 | 8 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 79 | 0.200 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 15 | 0.200 |
Why?
|
| Vaccination | 1 | 2021 | 32 | 0.190 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 45 | 0.190 |
Why?
|
| Self Report | 1 | 2023 | 223 | 0.190 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 928 | 0.190 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 10 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2021 | 86 | 0.180 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 134 | 0.170 |
Why?
|
| Fatigue | 1 | 2020 | 65 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 1201 | 0.170 |
Why?
|
| Appointments and Schedules | 1 | 2018 | 14 | 0.160 |
Why?
|
| Male | 5 | 2023 | 15143 | 0.160 |
Why?
|
| Patient Acuity | 1 | 2018 | 9 | 0.160 |
Why?
|
| Workload | 1 | 2018 | 33 | 0.160 |
Why?
|
| Stroke | 1 | 2022 | 272 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2020 | 244 | 0.150 |
Why?
|
| Depression | 1 | 2020 | 452 | 0.130 |
Why?
|
| Chicago | 1 | 2018 | 902 | 0.130 |
Why?
|
| Aged | 3 | 2022 | 9222 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2023 | 3524 | 0.110 |
Why?
|
| Inpatients | 2 | 2022 | 149 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3530 | 0.080 |
Why?
|
| Hemiplegia | 1 | 2022 | 5 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2022 | 16 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2023 | 146 | 0.050 |
Why?
|
| Paresis | 1 | 2022 | 17 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 370 | 0.050 |
Why?
|
| Hospitalization | 1 | 2023 | 316 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 266 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 353 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2018 | 70 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1366 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 715 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 2289 | 0.030 |
Why?
|
| Young Adult | 1 | 2022 | 2043 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 2371 | 0.030 |
Why?
|
| United States | 1 | 2018 | 2155 | 0.020 |
Why?
|